Skip to content

R&D at other companies

QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$2.3M-14.8%
Boston Scientific logo
Boston ScientificBSX
$516M+16.5%
Netflix logo
NetflixNFLX
$959.7M+16.6%
MSCI logo
MSCIMSCI
$49.6M+4.2%
Babcock & Wilcox Enterprises logo
Babcock & Wilcox EnterprisesBW
$803K+131%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$57.07M+12.2%

Other financials

Income statement

See full
Revenue$5.4M+215%
Operating income$6.5M+202%
Net income$3.1M+185%
EPS (diluted)$0.05+138%

Balance sheet

See full
Cash & equivalents$1.2M+6.1%
Total debt$10.5M-73.2%
Total equity$14.9M+229%
Total assets$62.4M+9.9%

Cash flow

See full
Operating cash flow-$2.8M-391%
CapEx$12.0K-87.0%
Free cash flow-$2.8M-424%

Valuation

See full
Market cap$848.4M+309%
Enterprise value$857.7M+250%
P/E47.7×+43.0×
P/S45.7×+15.8×

Profitability

See full
Operating margin-3.1%-1.6pp
Net margin95.7%-534pp
FCF margin-152.8%+77.2pp

Returns & leverage

See full
Return on equity-36.2%
Debt / equity0.7×
Current ratio0.4×+0.4×

Where this comes from

Reported directly by Falcon's Beyond Global in its filing.

Tagged under the XBRL concept fbyd:ResearchAndDevelopmentExpenseReversal.

The official record: Falcon's Beyond Global’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Falcon's Beyond Global's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Falcon's Beyond Global's R&D?
Falcon's Beyond Global (FBYD) reported R&D of $49.75K in Q4 2025.
How has Falcon's Beyond Global's R&D changed year-over-year?
Falcon's Beyond Global's R&D increased by 11.2% year-over-year, from $44.75K to $49.75K.
What does R&D mean?
The recognition of previously expensed research and development costs back into the income statement, often due to project cancellations or accounting adjustments. It indicates a change in the expected future economic benefit of innovation investments.